Evidence map›Paper›PMID 40002258›Full record

ArticleCancers2025

Risk Factors Predictive of Contralateral Recurrence of Upper Tract Urothelial Carcinoma Include Chronic Kidney Diseases and Postoperative Initiation of Dialysis.

Yi-Ru Wu, Ching-Chia Li, Yung-Shun Juan, Wei-Ming Li, Wen-Jeng Wu, Tsu-Ming Chien

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Integrative Analysis ofInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yi-Ru WuDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Ching-Chia LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Yung-Shun JuanDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.ORCID 0000-0002-0607-9093
Wei-Ming LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Wen-Jeng WuDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
Tsu-Ming ChienDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.ORCID 0000-0001-5503-5778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of the present study was to evaluate the impact of dialysis on patients with upper tract urothelial carcinoma (UTUC) who are undergoing surgical intervention, as well as to identify predictive factors linked to contralateral recurrence.

methodsA retrospective review was conducted on patients who underwent radical nephroureterectomy (RNU) for non-metastatic UTUC at our institution from 2000 to 2013. The contralateral recurrence rate was calculated using the Kaplan-Meier method, and multivariate logistic regression analysis was employed to examine the relationship between clinicopathological characteristics and contralateral recurrence.

resultsA total of 593 patients were included in this analysis, of which 31 (5.8%) experienced metachronous recurrence on the contralateral side. Kaplan-Meier analysis indicated a statistically significant reduction in the contralateral recurrence-free survival rate among female patients (

conclusionsIn conclusion, advanced CKD, a history of bladder cancer, and the initiation of new dialysis following surgery were identified as independent prognostic indicators for contralateral recurrence in patients with initial unilateral UTUC undergoing RNU. It is recommended that patients exhibiting these three adverse characteristics undergo rigorous monitoring of the contralateral upper urinary tract throughout the follow-up period.

Indexed as

chronic kidney diseasescontralateral recurrencehemodialysisupper tract urothelial carcinoma

Identifiers

PMID40002258
PMCPMC11853198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.